Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases?
The TWEAK/Fn 14 pathway is now well known for its involvement in the modulation of inflammation in various human autoimmune/chronic inflammatory diseases (AICID) including lupus, rheumatoid arthritis and multiple sclerosis. A panel of data is now available concerning TWEAK expression in tissues or b...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2013-12-01
|
| Serie: | Frontiers in Immunology |
| Soggetti: | |
| Accesso online: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00489/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|